Locations:
Search IconSearch
February 3, 2020/Neurosciences/Education

Learn to Integrate SEEG with Multimodal Imaging at This Brain Mapping Workshop

Experts to gather in Cleveland March 11-14

brain mapping in epilepsy

Effective use of stereoelectroencephalography (SEEG) for refractory epilepsy requires an accurate implantation strategy to ultimately enable a successful resective surgery. Providing detailed expert guidance in developing such a strategy is the overarching goal of Cleveland Clinic’s Ninth Brain Mapping Workshop, to take place in Cleveland from March 11 to 14, 2020.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The CME-certified course, titled “Imag(in)ing SEEG With Multimodal Integration,” will address the pre-SEEG workup — with multimodal guidance from MRI, EEG, MEG, SPECT and PET — as well as how multimodal findings are best used to inform surgical strategy development.

“A method for interpreting noninvasive multimodal data obtained during the planning phase of SEEG is essential to its success,” says Juan Bulacio, MD, an epileptologist with Cleveland Clinic’s Epilepsy Center who serves as one of the course’s five co-directors. “This procedure is not just for reviewing findings from different techniques. A fundamental interpretation is needed to integrate the various noninvasive findings according to their significance and their time sequence in the epileptogenic process. This brain mapping workshop will explore methods for doing so.”

Intimate workshop with expert faculty

The workshop is intimate in design, featuring opportunities for hands-on training and interaction with tutors dedicated to various case-based learning exercises. The faculty consists of epileptologists, neurosurgeons, neuroimaging specialists and neurophysiologists from Cleveland Clinic and other leading U.S. and European centers.

After kicking off Wednesday evening, March 11, with two hour-long introductory sessions on multimodality imaging and SEEG, the workshop structures most of the rest of its agenda around stages of the epileptogenic process:

  • Imaging interictal activity is the focus of most of Thursday. Sessions on MEG/EEG and source localization as well as interictal connectivity and EEG-fMRI are supplemented with case-based workshops with tutors; also included are opportunities for participants to make preimplantation maps. A case-based plenary discussion concludes the segment.
  • Imaging ictal activity comes to the fore late on Thursday, with sessions on analyzing clinical semiology videos and ictal SPECT as a snapshot of the seizure.
  • Imaging the lesion is the focus of most of Friday, with sessions devoted to MRI and PET followed by more case-based workshops with tutors, including an exercise where participants plan a resection based on evaluation findings. Again a case-based plenary session concludes the segment, with tutors presenting SEEG findings and discussions specific to pathology and surgical approach.
  • Integration of multimodal imaging and SEEG for planning resection is in the spotlight late on Friday, with discussions of how to represent multimodal imaging in relation to SEEG and how to prepare for surgery with SEEG.

Advertisement

After a Friday evening reception, the event concludes with a 3.5-hour Saturday morning session in which renowned epilepsy experts present in-depth cases for application of the workshop’s preceding insights.

All about integration

Participants can expect to come away with a clear understanding of how multimodal studies contribute to the pre-SEEG workup as well as how to integrate the neurophysiological assessment for that workup to define a surgical strategy.

“Attendees will be able to interpret SEEG recordings and cortical stimulation findings in the context of the pre-SEEG multimodal imaging data,” says course co-director Irene Wang, PhD, a staff scientist in Cleveland Clinic’s Epilepsy Center. “Emphasis will be put on linking 2D data to 3D representation; this is crucially import for the interpretation of SEEG, which is 3D in nature.”

For registration and more information, visit ccfcme.org/brainmapping20.

This activity has been approved for AMA PRA Category 1 Credit™.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad